Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. - Chen L; Wang Q; Gu M (Frontiers in endocrinology, 2026)